Laurion Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $14.7 Million - $20 Million	1,993,518 Added 219.64%	2,901,134 $21.8 Million
Q4 2023 Feb 14, 2024	SELL	$5.09 - $10.79 $11.6 Million - $24.5 Million	-2,270,563 Reduced 71.44%	907,616 $8.95 Million
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $7.51 Million - $16.4 Million	-1,647,556 Reduced 34.14%	3,178,179 $23.7 Million
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $1.71 Million - $3.03 Million	238,461 Added 5.2%	4,825,735 $37.2 Million
Q1 2022 May 16, 2022	BUY	$6.16 - $18.03 $4.09 Million - $12 Million	663,561 Added 16.91%	4,587,274 $32.8 Million
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $1.24 Million - $2.69 Million	65,096 Added 1.69%	3,923,713 $90.3 Million
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $69.5 Million - $144 Million	3,858,617 New	3,858,617 $141 Million

291

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.32B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.